Project Grant R56DK135533
Award Date
9/15/24
Completion Date
8/31/26
Dollars Obligated
$600K
Similar Awards
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $938,470 to the University of Massachusetts Medical School to investigate a novel adipokine that may resolve non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) in mouse models. The award period runs from September 1, 2024 to June 30, 2028. The research aims...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $1,593,841 to The Children's Hospital Corporation (dba Boston Children's Hospital) to conduct research on the mechanisms that integrate type 2 diabetes (T2D) and non-alcoholic fatty liver disease (NAFLD). The research aims to investigate how hepatic insulin resistance drives the...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $172,060 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to conduct research on the role of the unfolded protein response (UPR) in the pathogenesis of non-alcoholic steatohepatitis (NASH). The research aims to understand the mechanism of UPR loss...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) provides $243,590 to the University of Chicago to study the role of the mitophagy receptor BNIP3 in regulating lipid homeostasis in the liver. The goal is to define the mechanisms by which BNIP3 decreases lipid droplet content through promoting mitophagy and lipophagy, particularly in the...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $707,389 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to the Icahn School of Medicine at Mount Sinai. The grant, awarded on August 15, 2024, will fund a study titled "Targeting Nonalcoholic Fatty Liver Disease During the Reproductive Period to Improve Women's Health Outcomes." The study aims to evaluate the evolution of nonalcoholic...
This federal Project Grant award of $433,125.00 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research conducted by the University of California, Los Angeles (UCLA) to investigate the role of TIM-4 signaling in nonalcoholic steatohepatitis (NASH) liver transplant ischemia/reperfusion injury. The research aims to determine if TIM-4-derived foamy macrophages in NASH liver grafts are a risk factor for primary graft...
This Project Grant award of $1,508,800.00, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research conducted by The University of Texas Southwestern Medical Center (UT Southwestern) to elucidate the role of somatic genetics in chronic liver disease pathways. The research aims to 1) identify adaptive genetic pathways specific to liver disease etiologies,...
This $391,250 Project Grant awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) will support research on extracellular vesicle-dependent RNA signaling in metabolism. The project aims to identify key proteins involved in the delivery of adipose microRNAs into liver cells via extracellular vesicles, and to determine if this RNA delivery mechanism is necessary for...
The U.S. Department of Health and Human Services' National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $361,400 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to Oncotrap Inc. The funding supports the development of a bispecific single-domain antibody targeting the chemokines CCL2 and CCL5 for the treatment of non-alcoholic steatohepatitis (NASH). The award will enable Oncotrap to generate a human version...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $2,123,110 Cooperative Agreement under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to the University of Washington. The project, titled "Immunometabolism and the Cardio-Renal Axis in T1D-Associated Atherosclerosis: Insights from the CARE T1D Biobank," aims to dissect the relationship between T cell populations and cardiovascular complications in type 1...